The Impact of Treatment Noncompliance on Mortality in People With Type 2 Diabetes
Open Access
- 11 May 2012
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 35 (6), 1279-1284
- https://doi.org/10.2337/dc11-1277
Abstract
OBJECTIVE: To assess the association of compliance with treatment (medication and clinic appointments) and all-cause mortality in people with insulin-treated type 2 diabetes. RESEARCH DESIGN AND METHODS: Data were extracted from U.K. general practice records and included patients (N = 15,984) who had diagnostic codes indicative of type 2 diabetes or who had received a prescription for an oral antidiabetic agent and were treated with insulin. Records in the 30 months before the index date were inspected for clinical codes (recorded at consultation) indicating medication noncompliance or medical appointment nonattendance. Noncompliance was defined as missing more than one scheduled visit or having at least one provider code for not taking medications as prescribed. Relative survival postindex date was compared by determining progression to all-cause mortality using Cox proportional hazards models. RESULTS: Those identified as clinic nonattenders were more likely to be smokers, younger, have higher HbA1c, and have more prior primary care contacts and greater morbidity (P < 0.001). Those identified as medication noncompliers were more likely to be women (P = 0.001), smokers (P = 0.014), and have higher HbA1c, more prior primary care contacts, and greater morbidity (all P < 0.001). After adjustment for confounding factors, medication noncompliance (hazard ratio 1.579 [95% CI 1.167–2.135]), clinic nonattendance of one or two missed appointments (1.163 [1.042–1.299]), and clinic nonattendance of greater than two missed appointments (1.605 [1.356–1.900]) were independent risk factors for all-cause mortality. CONCLUSIONS: Medication noncompliance and clinic nonattendance, assessed during routine care by primary care physicians or their staff, were independently associated with increased all-cause mortality in patients with type 2 diabetes receiving insulin.Keywords
This publication has 21 references indexed in Scilit:
- Clinical inertia in management of T2DMPrimary Care Diabetes, 2010
- Estimation of primary care treatment costs and treatment efficacy for people with Type 1 and Type 2 diabetes in the United Kingdom from 1997 to 2007*Diabetic Medicine, 2010
- Correlates of Insulin Injection OmissionDiabetes Care, 2010
- Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: A retrospective cohort studyClinical Therapeutics, 2009
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of TherapyDiabetes Care, 2009
- The importance of defining periods of complete mortality reporting for research using automated data from primary carePharmacoepidemiology and Drug Safety, 2008
- Prevalence, Treatment, and Control of Diagnosed Diabetes in the U.S. National Health and Nutrition Examination Survey 1999–2004Annals of Epidemiology, 2008
- Adherence to insulin and its association with glycaemic control in patients with type 2 diabetesQJM: An International Journal of Medicine, 2007
- Patient Adherence Improves Glycemic ControlThe Diabetes Educator, 2005
- Missed Appointments and Poor Glycemic ControlMedical Care, 2004